JP2017501154A5 - - Google Patents

Download PDF

Info

Publication number
JP2017501154A5
JP2017501154A5 JP2016539318A JP2016539318A JP2017501154A5 JP 2017501154 A5 JP2017501154 A5 JP 2017501154A5 JP 2016539318 A JP2016539318 A JP 2016539318A JP 2016539318 A JP2016539318 A JP 2016539318A JP 2017501154 A5 JP2017501154 A5 JP 2017501154A5
Authority
JP
Japan
Prior art keywords
angiotensin
rate
catecholamine
norepinephrine
mcg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539318A
Other languages
English (en)
Japanese (ja)
Other versions
JP6824739B2 (ja
JP2017501154A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/071186 external-priority patent/WO2015095535A1/en
Publication of JP2017501154A publication Critical patent/JP2017501154A/ja
Publication of JP2017501154A5 publication Critical patent/JP2017501154A5/ja
Application granted granted Critical
Publication of JP6824739B2 publication Critical patent/JP6824739B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539318A 2013-12-18 2014-12-18 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ Active JP6824739B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361917576P 2013-12-18 2013-12-18
US61/917,576 2013-12-18
US201461955706P 2014-03-19 2014-03-19
US61/955,706 2014-03-19
PCT/US2014/071186 WO2015095535A1 (en) 2013-12-18 2014-12-18 Angiotensin ii alone or in combination for the treatment of hypotension

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019153144A Division JP7175506B2 (ja) 2013-12-18 2019-08-23 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ

Publications (3)

Publication Number Publication Date
JP2017501154A JP2017501154A (ja) 2017-01-12
JP2017501154A5 true JP2017501154A5 (https=) 2018-02-08
JP6824739B2 JP6824739B2 (ja) 2021-02-03

Family

ID=53367119

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016539318A Active JP6824739B2 (ja) 2013-12-18 2014-12-18 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2019153144A Active JP7175506B2 (ja) 2013-12-18 2019-08-23 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2022113327A Withdrawn JP2022137224A (ja) 2013-12-18 2022-07-14 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2025078759A Pending JP2025114753A (ja) 2013-12-18 2025-05-09 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019153144A Active JP7175506B2 (ja) 2013-12-18 2019-08-23 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2022113327A Withdrawn JP2022137224A (ja) 2013-12-18 2022-07-14 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2025078759A Pending JP2025114753A (ja) 2013-12-18 2025-05-09 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ

Country Status (25)

Country Link
US (7) US9220745B2 (https=)
EP (2) EP2986308B1 (https=)
JP (4) JP6824739B2 (https=)
KR (4) KR20230051721A (https=)
CN (4) CN111920939A (https=)
AU (3) AU2014364528C1 (https=)
BR (1) BR112016013961A2 (https=)
CA (1) CA2933601A1 (https=)
CY (1) CY1122604T1 (https=)
DK (2) DK3607962T3 (https=)
EA (1) EA037823B1 (https=)
ES (2) ES2771749T3 (https=)
FI (1) FI3607962T3 (https=)
HR (2) HRP20200009T1 (https=)
HU (1) HUE047062T2 (https=)
IL (1) IL246162B (https=)
LT (2) LT2986308T (https=)
MX (2) MX380968B (https=)
NZ (1) NZ721089A (https=)
PL (2) PL3607962T3 (https=)
PT (2) PT3607962T (https=)
RS (2) RS59804B1 (https=)
SI (2) SI3607962T1 (https=)
SM (2) SMT202000018T1 (https=)
WO (1) WO2015095535A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
RS59804B1 (sr) 2013-12-18 2020-02-28 The George Washington University A Congressionally Chartered Not For Profit Corporation Angiotenzin ii u kombinaciji za lečenje hipotenzije
CA2954016A1 (en) * 2014-07-08 2016-01-14 La Jolla Pharma, Llc Methods for treating hypotension
WO2016153558A1 (en) 2015-03-20 2016-09-29 Atkinson Arthur J Use of angiotensin ii (aii) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps
EP3400000B1 (en) * 2016-01-07 2023-12-06 La Jolla Pharma, LLC Methods for administering angiotensin ii
KR20180108630A (ko) * 2016-01-07 2018-10-04 라 졸라 파마슈티칼 컴파니 혈관수축제의 투여 방법
US11583568B2 (en) 2017-04-14 2023-02-21 La Jolla Pharma, Llc Methods for administering angiotensin II
US20190183962A1 (en) * 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto
WO2023244552A1 (en) * 2022-06-15 2023-12-21 Virginia Commonwealth University Methods for fluid resuscitation of an organ donor
EP4633658A1 (en) * 2022-12-12 2025-10-22 Proletariat Therapeutics, Inc. Methods of treating cardiac injury

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
US6592865B2 (en) 2001-06-04 2003-07-15 Human Genome Sciences, Inc. Methods and compositions for modulating ACE-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
NO20034952D0 (no) 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
EP1699495A2 (en) 2003-11-06 2006-09-13 Amersham Health AS Conjugates of angiotensin ii and an imaging moiety
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
DE602006021600D1 (de) 2005-09-29 2011-06-09 Fibrogen Inc Verfahren zur senkung des blutdrucks
CN101351215A (zh) * 2005-12-30 2009-01-21 霍华德·弗洛里实验生理学及医学研究所 治疗方法
US20070293552A1 (en) 2006-06-15 2007-12-20 Gorczynski Richard J Antihypertensive therapy method
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
CN101795675A (zh) 2006-11-17 2010-08-04 达沃尔泰拉公司 使用具有Eudragit包衣的Zn/果胶珠粒进行的结肠递送
WO2009009907A1 (en) * 2007-07-18 2009-01-22 The University Of British Columbia Use of vasopressin-receptor agonists for the treatment of septic shock
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
WO2010062896A1 (en) 2008-11-28 2010-06-03 Abbott Laboratories Stable antibody compositions and methods for stabilizing same
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
FR2959414B1 (fr) * 2010-04-30 2016-01-08 Luc Quintin Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
WO2012009545A1 (en) 2010-07-14 2012-01-19 Cumberland Emerging Technologies, Inc Methods of treating hepatorenal syndrome and hepatic encephalopathy with thromboxane-a2 receptor antagonists
CN105592855A (zh) 2013-04-26 2016-05-18 拉卓拉药物公司 用于治疗肾衰竭的组合物和方法
RS59804B1 (sr) 2013-12-18 2020-02-28 The George Washington University A Congressionally Chartered Not For Profit Corporation Angiotenzin ii u kombinaciji za lečenje hipotenzije
US20150286797A1 (en) 2014-04-02 2015-10-08 David R. Ratto System and method for administering medication
CA2954016A1 (en) 2014-07-08 2016-01-14 La Jolla Pharma, Llc Methods for treating hypotension
KR20180108630A (ko) 2016-01-07 2018-10-04 라 졸라 파마슈티칼 컴파니 혈관수축제의 투여 방법
EP3400000B1 (en) 2016-01-07 2023-12-06 La Jolla Pharma, LLC Methods for administering angiotensin ii
US11583568B2 (en) 2017-04-14 2023-02-21 La Jolla Pharma, Llc Methods for administering angiotensin II
US20190183962A1 (en) 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto

Similar Documents

Publication Publication Date Title
JP2017501154A5 (https=)
EP4233861A3 (en) Compositions for treatment of essential tremor
JP2022009125A5 (https=)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
NZ598534A (en) Dosage regimen of an s1p receptor modulator
RU2014141893A (ru) Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких
PH12015502465A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
RU2018121615A (ru) Модуляторы активности комплемента
PH12016501357A1 (en) Pharmaceutical preparation containing pyridylamino acetic acid compound
JP2018526460A5 (https=)
JP2017519799A5 (https=)
EP4700016A3 (en) Pharmaceutical agent for treating amyotrophic lateral sclerosis or suppressing disease progress thereof
JP2015532293A5 (ja) 糖尿病患者における心不全の治療用組成物
Sahu et al. Comparison of bolus phenylephrine, ephedrine and mephentermine for maintenance of arterial pressure during spinal anaesthesia in caesarean section–a clinical study
JP2019507786A5 (https=)
JP2016510040A5 (https=)
JP2019535830A5 (https=)
RU2016103098A (ru) Способ предотвращения и/или лечения хронической травматической энцефалопатии - ii
JP2015512923A5 (https=)
RU2012116226A (ru) Бронхолитическое средство на основе простагландина
NZ708511A (en) Methods for controlling blood pressure and reducing dyspnea in heart failure
JP2015535258A5 (https=)
JP2016503406A5 (https=)
JP2016510738A5 (https=)
RU2013148539A (ru) Алиспоривир для лечения инфекции вируса гепатита с